RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marian Sepulveda Orengo to Dopamine Uptake Inhibitors

Back to Details
This is a "connection" page, showing publications Marian Sepulveda Orengo has written about Dopamine Uptake Inhibitors.
Marian Sepulveda Orengo
Connection Strength
0.470
Dopamine Uptake Inhibitors
  1. Morales-Silva RJ, Perez-Perez Y, Alvarado-Torres J, Rivera-Aviles N, Rodriguez-Torres G, Gelpi-Dominguez U, Dominguez-Padovani B, Amador-Maldonado A, Sepulveda-Orengo MT. Sex-specific effects of chronic stress prior to cocaine exposure on cue- vs drug-induced relapse after prolonged abstinence. Behav Brain Res. 2024 10 02; 474:115197.
    View in: PubMed
    Score: 0.210
  2. Sepulveda-Orengo MT, Healey KL, Kim R, Auriemma AC, Rojas J, Woronoff N, Hyppolite R, Reissner KJ. Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression. Neuropsychopharmacology. 2018 05; 43(6):1212-1223.
    View in: PubMed
    Score: 0.130
  3. Kim R, Sepulveda-Orengo MT, Healey KL, Williams EA, Reissner KJ. Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal. Neuropharmacology. 2018 Jan; 128:1-10.
    View in: PubMed
    Score: 0.130
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support